Home > Publications
Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician
4. Tobacco
Table of contents
- Acknowledgments
- Abbreviations
- Preface
- Introduction
1. Levels of evidence
2. Management of people with comorbidity of mental disorders and substance use
3. The common drug groups
4. Tobacco
5. Depression and substance use- 5.1 Depression
- 5.2 Comorbidity with depression
- 5.3 Major clinical issues with depression and cannabis/ hallucinogen use
- 5.4 Major clinical issues with depression and alcohol use
- 5.5 Major clinical issues with depression and opioid use
- 5.6 Major clinical issues with depression and stimulant (including methamphetamine) use
- 5.7 Major clinical issues with depression and benzodiazepine use
- 5.8 Major clinical issues with depression and inhalant/ solvent use
6. Anxiety disorders and substance use- 6.1 Anxiety
- 6.2 Comorbidity with anxiety disorders
- 6.3 Major clinical issues with anxiety disorders and cannabis/ hallucinogen use
- 6.4 Major clinical issues with anxiety disorders and alcohol use
- 6.5 Major clinical issues with anxiety disorders and opioid use
- 6.6 Major clinical issues with anxiety disorders and stimulant (including methamphetamine) use
- 6.7 Major clinical issues with anxiety disorders and benzodiazepine use
- 6.8 Major clinical issues with anxiety disorders and inhalent/ solvent use
7. Psychosis (schizophrenia and bipolar disorder) and substance use- 7.1 Psychosis
- 7.2 Comorbidity with Psychosis
- 7.3 Major clinical issues with psychosis and cannabis/ hallucinogen use
- 7.4 Major clinical issues with psychosis and alcohol use
- 7.5 Major clinical issues with psychosis and opioid use
- 7.6 Major clinical issues with psychosis and stimulant (including methampetamine) use
- 7.7 Major clinical issues with psychosis and benzodiazepine use
- 7.8 Major clinical issues with psychosis and inhalent/ solvent use
8. Personality disorders and substance use- 8.1 Personality disorders
- 8.2 Comorbidity with personality disorders
- 8.3 Major clinical issues with personality disorders and cannabis/ hallucinogen use
- 8.4 Major clinical issues with personality disorders and alcohol use
- 8.5 Major clinical issues with personality disorders and opioid use
- 8.6 Major clinical issues with personality disorders and stimulant (including methamphetamine) use
- 8.7 Major clinical issues with personality disorders and benzodiazepine use
- 8.8 Major clinical issues with personality disorders and inhalant/ solvent use
9. Eating disorders and substance use- 9.1 Eating disorders
- 9.2 Comorbidity with eating disorders
- 9.3 Major clinical issues with eating disorders and cannabis/ hallucinogen use
- 9.4 Major clinical issues with eating disorders and alcohol use
- 9.5 Major clinical issues with eating disorders and opioid use
- 9.6 Major clinical issues with eating disorders and stimulant (including methamphetamine) use
- 9.7 Major clinical issues with eating disorders and benzodiazepine use
- 9.8 Major clinical issues with eating disorders and inhalant/ solvent use
10. Somatoform disorders and substance use- 10.1 Somatoform disorders
- 10.2 Comorbidity with somatoform disorders
- 10.3 Major clinical issues with somatoform disorders and cannabis/ hallucinogen use
- 10.4 Major clinical issues with somatoform disorders and alcohol use
- 10.5 Major clinical issues with somatoform disorders and opioid use
- 10.6 Major clinical issues with somatoform disorders and stimulant (including methamphetamine) use
- 10.7 Major clinical issues with somatoform disorders and benzodiazepine use
- 10.8 Major clinical issues with somatoform disorders and inhalant/ solvent use
11. Gambling and substance use- 11.1 Gambling
- 11.2 Comorbidity with gambling
- 11.3 Major clinical issues with gambling and cannabis/ hallucinogen use
- 11.4 Major clinical issues with gambling and alcohol use
- 11.5 Major clinical issues with gambling and opioid use
- 11.6 Major clinical issues with gambling and stimulant (including methamphetamine) use
- 11.7 Major clinical issues with gambling and benzodiazepine use
- 11.8 Major clinical issues with gambling and inhalant/ solvent use
12. Brain injury, mental disorders and substance use- 12.1 Brain injury
- 12.2 Do mental disorders predispose individuals to brain injury?
- 12.3 Does substance use predispose individuals to brain injury?
- 12.4 Does brain injury predispose individuals to mental disorders or to suicide?
- 12.5 Does brain injury predispose individuals to substance use?
- 12.6 Does brain injury impact on treatment approaches to mental disorders and substance use?
- 13. Bibliography
14. Appendices

